Review Article
Desmoplastic Small Round Cell Tumor: Current Management and Recent Findings
| Author | Drug | Number of cases | Benefit |
|
Thijs et al., 2010 [12] | Temsirolimus | 1 | PFS 40 weeks |
Lopez-Gonzales, 2011 [13] | Cisplatin-Campto trabectedin | 1 | PDPFS 8 months | Chao, 2010 | Imatinib mesylate | 2 | PFS 0.2 and 1.1 months |
Mrabti et al., 2011 [14] | Anthracyclin | 1 | — | Outc’s observatory ASCO 2010 #10097 | Sunitinib | 2 | PFS 2 and 6 months | Outc’s observatory ASCO 2010 #10097 | Sorafenib | 2 | PFS 3 months: stop at 3 months for toxicity |
|
|